Medicine

The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda A phase 3 international trial evaluating a new personalised immunotherapy treatment for

Neurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide Researchers at the University of Cambridge have developed small, flexible

Despite ever increasing funding, clinical trials in primary biliary cholangitis (PBC) continue to struggle. PBC is an often silent, rare disease which means recruitment

Bacteroides fragilis in the gut improves immunity and immunotherapy treatment responses Researchers from the Francis Crick Institute, the National Cancer Institute of the US

The inherited disorder is caused by genetic mutations that affects haemoglobin production Nova Laboratories’ Xromi (hydroxycarbamide) has received approval from the Medicines and Healthcare

Bladder cancer, including papillary tumours, is the ninth most common cancer type worldwide Researchers from ETH Zurich and University Hospital Basel have revealed new

The progressive neurological condition affects more than six million people worldwide Researchers from the University of Cambridge have designed and used an artificial-intelligence (AI)-based

An estimated 50% of human genes follow a circadian cycle, many of which are active in the liver A new study conducted by researchers

GPT-4 is trained on datasets to offer eye-related advice, diagnosis and management suggestions A new study led by researchers from the University of Cambridge

Cambridge Cognition has announced Alex Livingstone-Learmonth as CCO Cambridge Cognition has announced the appointments of Alex Livingstone-Learmonth as Chief Commercial Officer and Annabelle Miles

British In Vitro Diagnostic Association has appointed Helen Dent as Chief Executive The British In Vitro Diagnostic Association (BIVDA) has appointed Helen Dent as

Chronic liver disease and associated cirrhosis account for one million deaths every year Boehringer Ingelheim and Ochre Bio have partnered to discover and develop

The paper identifies the roles and differences between LARP4A and LARP4B in sarcoma and carcinoma cancers A Medical Research Council doctoral training partnership (MRC-DTP)

The key to a culture-conscious pharma partnership Partnerships are not just about expanding our reach and product portfolio, but also about creating a powerful

The new method could help to prevent severe side effects caused by enantiomer drugs Scientists from the University of Edinburgh’s School of Chemistry have

The tool will help people find out about clinical trials for myeloma, MGUS, SMM and AL amyloidosis Myeloma Patients Europe (MPE) has launched the

X-linked Charcot-Marie-Tooth is the second most common form of the rare peripheral neuropathy disease The CMT Research Foundation (CMTRF) has invested in a study

According to the World Health Organization, CVDs are responsible for an estimated 17.9 million deaths every year Researchers from the universities of Oxford, Nottingham

The progressive neurodegenerative condition is the most common form of dementia Researchers from University College London (UCL) have begun recruiting volunteers to assess the

Severe acute malnutrition is responsible for nearly half of all child deaths globally and affects 17 million children annually A trial led by researchers

The rise of pharmacies and their new role in primary healthcare

The neurodegenerative condition currently affects more than 944,000 people living in the UK Researchers from the Universities of Manchester, Nottingham, Edinburgh and Dundee have

The launch is part of the NIHRs £42m funding to establish 14 new HRCs across England Guy’s and St Thomas’ and King’s College London

Our future robot overlords are playing the long game

Both will develop cancer vaccine candidates in selected haematological and solid tumour indications CureVac and the University of Texas’s MD Anderson Cancer Center have

Involving 152 patients, the SENTINEL trial aims to cut lung transplant rejection by up to 50% A new clinical trial being led by the

Breast cancer was responsible for 2.3 million diagnoses and 670,000 deaths globally in 2022 A new report led by the University of Cambridge and

The Tyche model could help clinicians and researchers capture crucial information in images Researchers from the Massachusetts Institute of Technology (MIT), the Broad Institute

The findings suggest why children tend to experience milder symptoms compared to older adults Researchers from University College London (UCL) and the Wellcome Sanger

Both companies will facilitate career progression while advancing the life sciences industry The European Laboratory Research and Innovation Group (ELRIG) UK has announced its

Solid organ transplantation is used to treat end-stage organ failure, including the kidneys Bio-Rad Laboratories and Oncocyte Corporation have partnered to develop and commercialise

Liver cirrhosis, caused by long-term liver damage, is estimated to affect around 100 million people worldwide Researchers from University College London (UCL) have invented

Approximately 14% of the competition-submitted proposals were selected to receive funding Nine researchers from University College London (UCL) have secured nearly £560m in funding

Affecting over 500,000 people in the UK, IBD comprises Crohn’s disease and ulcerative colitis The study, published in Nature Immunology, could help identify new

NSCLC is the most common type of lung cancer and is responsible for up to 85% of all cases Researchers from the Francis Crick

Both partners’ will leverage their nuclear research facilities and expertise to develop new health interventions King’s College London’s (KCL) Biomedical Engineering and Imaging Sciences

In today’s rapidly evolving healthcare landscape, transformation is key to success and medical affairs teams play a vital role in making it happen. But

Prostate cancer is responsible for around 12,000 deaths a year in the UK and is the second biggest cause of death for men Researchers

RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR Researchers from the Universities of Bristol, Bath, King’s

Solid tumour cancers account for 90% of adult human cancers and 50% of childhood malignancies Bio-Rad Laboratories and Alleghany Health Network (AHN) have partnered

The most common form of cancer in men is responsible for 12,000 deaths every year in the UK A clinical trial led by researchers

Both will validate the clinical performance of two new diagnostic tests for regulatory submission Culmination Bio has announced a partnership with BillionToOne to develop

Hepatocellular carcinoma is one of the leading causes of cancer-related deaths worldwide Researchers from the Johns Hopkins Kimmel Cancer Center and its Convergence Institute

Around three million people in the UK were estimated to be living with cancer in 2022 Alliance Healthcare has announced it has opened access

The project aims to advance therapeutics for tuberculosis, malaria and hepatitis C in LMICs A research project led by the University of Liverpool has

Affecting 80,000 people in England, 12% of brain tumour patients survive beyond five years of diagnosis myTomorrows has announced a new partnership with a

Hoxa9 and b-catenin molecules are a rare population of self-renewing HSCs found in bone marrow Researchers from King’s College London’s (KCL) Comprehensive Cancer Centre

The fatal, progressive neurological condition currently affects around 5,000 people in the UK Researchers from the University of Edinburgh and the University of Aberdeen

The project will assist researchers and companies in training the technology for healthcare settings A project being led by King’s College London (KCL) has

The progressive neurodegenerative disease is estimated to affect 24 million people globally Researchers from the University of British Columbia in Canada have revealed that

The third most common and serious form of cancer affects over 43,000 people every year in the UK In partnership between The Royal Marsden

Two out of three people with the neurodegenerative condition experienced delirium in hospital Researchers from Newcastle University have revealed that people living with Parkinson’s

The genetic condition affects one in 279 people in England and significantly increases cancer risk Researchers from the Institute of Cancer Research (ICR), in

Amylyx has appointed Andrew Caldwell as General Manager UK and Ireland Amylyx has announced the appointment of Andrew Caldwell as General Manager UK and Ireland. He joins the company

Paul Adams is new Chief Executive Officer of LloydsPharmacy Clinical Homecare Paul Adams has been announced as the new Chief Executive Officer of LloydsPharmacy Clinical Homecare,

Besins has appointed Irina Spirieva as General Manager for UK and Ireland Besins Healthcare has announced the appointment of Irina Spirieva as its new General Manager for

Healthcare agencies can submit their entries free of charge with a deadline of 30 April The 2024 edition of PMLiVE’s T40 list of creative

Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m The University of Liverpool has announced

The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases Strand Therapeutics, a Massachusetts Institute of Technology

PhaSER will provide 8HUM mouse models for the TDI to accelerate a pipeline of novel therapeutic targets PhaSER Biomedical has announced its long-term partnership

The progressive and incurable brain disorder currently affects approximately 100 patients worldwide LifeArc has announced that it has funded a pivotal clinical trial at

Ipsen has appointed Ioana Parsons as General Manager UK & Ireland Ipsen has announced the appointment of Ioana Parsons as General Manager of the company’s UK & Ireland affiliate.

Clinical trials, the cornerstone of medical advancement, have stood largely unchanged over the past two decades. An evolution has begun, however, indicating a future

Estimated to affect 2.5 million people in the US, synucleinopathies comprise four neurodegenerative disorders Neurologists from the Beth Israel Deaconess Medical Center (BIDMC) have

LDHA and GOT1 enzymes successfully targeted and halted energy production in hard-to-reach cancer cells Researchers from the Francis Crick Institute have revealed how cancer

Unleashing the potential of pharmacies through Pharmacy First

Dementia is estimated to affect 850,000 people in the UK and costs the nation around £23bn a year Innovate UK has awarded ten new

These types of conditions are responsible for 25% of all UK deaths and affect 7.6 million people nationally The British Heart Foundation (BHF), the

We need more women in pharma and life sciences

The globally fast-growing progressive neurological condition affects around 153,000 people in the UK Parkinson’s UK has announced that it is funding four new research

The bacterial infection transmitted by ticks affects nearly half a million people in the US every year Researchers from the Massachusetts Institute of Technology

Rare kidney diseases are a group of conditions which account for over 5% of people living with chronic kidney disease A new study led

In 2021, neurological conditions, including Alzheimer’s disease, affected approximately 3.4 billion people globally In a new study funded by the Bill & Melinda Gates

The fatal motor neurone disease currently does not have a cure available to treat patients The ALS Association and myTomorrows have partnered to improve

The SOL3D pipeline addresses research challenges in relation to equipment, expertise and cost Scientists from King’s College London’s (KCL) UK Dementia Research Institute’s (UK

Up to 20% of prostate cancer cases are classified as castration-resistant AstraZeneca (AZ) and Merck & Co – known as MSD outside the US

The centre will deliver free training, outreach materials and programmes The University of Birmingham is set to lead UK-wide virtual reality (VR)-assisted training in

In the study, the Lymphoma Artificial Reader System accurately detected 90% of lymphatic cancers Researchers from Chalmers University of Technology in Sweden have developed

Affecting 55 million people globally, dementia impairs the ability to remember, think or make decisions Roche and the Cardiff University Brain Research Imaging Centre

Every year, missed hospital appointments are estimated to cost the NHS £1.2bn The NHS has announced that it’s set to roll out artificial intelligence

More than 3,700 cases of mpox have been identified in the UK since May 2022 The National Institute for Health and Care Research (NIHR)

Approaches to M&As in pharma points to each company’s philosophy

Stirred has revealed that Amy Greenwood will lead ‘Stirred Well’ Stirred has announced the arrival of former Evoke consumer health director, Amy Greenwood, to lead its new

The progressive neurological disorder affects approximately 12,400 people in Scotland AbbVie’s Produodopa (foslevodopa-foscarbidopa) has been accepted by the Scottish Medicines Consortium (SMC) for use

Around 200,000 people in the US are expected to be diagnosed with the skin cancer this year Researchers from the Johns Hopkins Kimmel Cancer

Globally, cancer is currently the most leading cause of death due to disease among children The Institute of Cancer Research (ICR) has announced it

Between October 2023 and March 2024, the UKHSA said that 733 cases of measles were reported in England The NHS has announced it is

The HYPIEND project consists of 14 partners from eight European countries King’s College London (KCL) has announced that it is one of 14 partners

The neurodevelopmental condition affects up to four in 100 children A new study led by researchers at University College London (UCL) and other collaborators

The gamma treatment also shows potential for treating patients living with neurological diseases Researchers from the Massachusetts Institute of Technology (MIT) have shown that

The rare epileptic seizure disorder currently affects around one in 42,000 people in the UK The Medicines and Healthcare products Regulatory Agency (MHRA) has

Secondary breast cancer is an important risk factor after receiving radiotherapy for Hodgkin lymphoma NHS England has responded to the recent ministerial statement by

Ovarian high-grade serous carcinoma is the most common form of aggressive ovarian cancer Researchers from Johns Hopkins Kimmel Cancer Center and the Johns Hopkins

The project will train a newly developed AI system on data collected from participating men and women Researchers from the University of Glasgow’s James

CDH affects one in 5,000 babies born in the UK, impacting the foetus’ development of vital organs Researchers from University College London (UCL) and

The non-invasive tool can also improve patient stratification and monitor disease progression Researchers from King’s College London (KCL) have developed a deep learning framework

Women with atypical endometrial hyperplasia have an increased risk of developing cancer Researchers from the University of Edinburgh have revealed that improved patient care

Around 900,000 people in the UK are affected by the progressive neurodegenerative disease Researchers from University College London (UCL), in collaboration with the University

In the UK alone, the aggressive form of cancer affects around 52,000 men every year Researchers from the University of Oxford and the University

Aphasia is a language disorder caused by some form of brain damage, including stroke Researchers from the Neurotherapeutics Group at University College London’s Queen

TMR-CT will help doctors select treatment and predict the spread of lung cancer in patients Imperial College London (ICL) researchers have used artificial intelligence

Different factors, such as illness duration and virus variant, impacted patients cognitive abilities Imperial College London (ICL) researchers have revealed that people who have

Approximately 80% of patients taking Remicade from diagnosis had symptoms controlled Researchers from the University of Cambridge have revealed a ‘top-down’ treatment strategy involving

In 2024, Rare Disease Day falls on an appropriately rare calendar date: 29 February, a leap year. This international awareness campaign provides the perfect opportunity to highlight the

Breast cancer is responsible for around 47,000 new cases in England every year Researchers from the Institute of Cancer Research (ICR) have revealed a

The inherited fatal heart muscle condition affects one in every 500 adults in the UK Researchers from University College London (UCL) have developed a

Eight out of ten patients who took the test were discharged without needing further testing The NHS has announced that a simple sponge-on-a-string test

The white paper outlines three strategic recommendations to support further research Researchers from King’s College London and Erasmus MC in the Netherlands have called

Every year, tuberculosis, malaria and HIV cause over five million deaths worldwide PhaSER Biomedical has received a grant from the Bill & Melinda Gates

Why haven’t we been delivering more life sciences research in primary care? Since the COVID-19 pandemic there has been an increasing recognition that primary

Growing cerebral organoids from foetal human brain tissue For the first time, scientists have grown cerebral organoids from human foetal brain tissue. This is another leap in the

Results showed robust responses in patients with pancreatic and colorectal cancer Elicio Therapeutics has announced positive phase 1 clinical data suggesting that its cancer

In England, around 1,100 cases of bowel cancer are caused by the inherited condition every year The NHS has announced it is offering routine

The immunosuppressant reduced inflammation in patients with the skin condition after three days Researchers from King’s College London (KCL) have investigated the early effects

The trial is recruiting patients in Leeds, Manchester, Oxford, London, Cambridge and Kent The University of Leeds has launched a trial funded by the

Pharmacy First will enable patients to receive treatment for seven common conditions The NHS has launched a new campaign to raise awareness of the

A streptococcal bacterial infections are estimated to affect around 50 million people worldwide Researchers from Imperial College London (ICL) and the University of California

For life sciences organisations, the pressure to speed up the time to market of new drugs and therapies continues at pace, alongside the need

The nanogels, in combination with rolipram, contributed to the recovery of injured tissue Researchers from the Instituto di Ricerche Farmacologiche Mario Negri IRCCS and

The new programme will engage with children and young people under the age of 18 years Innovative Trials has announced a new initiative designed

Participants who received COMPASS showed a clinically significant improvement after 12 weeks Researchers from King’s College London’s (KCL) Institute of Psychiatry, Psychology and Neuroscience

The study aims to improve the representation of ethnic diversity within Parkinson’s research A study led by researchers at Queen Mary University and University

NRTX-1001 is being assessed for drug-resistant mesial temporal lobe epilepsy Neurona Therapeutics has announced that it has secured $120m in funding to help advance

Cardiac quantitative susceptibility mapping successfully visualised iron deposits in patients Researchers from King’s College London (KCL) have investigated a new technique for diagnosing and

CLM-HT01 improved blood pressure and minimised adverse reactions in patients Closed Loop Medicine has shared positive results of its novel drug and proprietary technology

In Europe, stroke-related brain-bleed deaths are expected to increase by 8.9% by 2050 Researchers from King’s College London (KCL) have predicted that the number

The report includes five recommendations for the government to address these issues The Academy of Medical Sciences has published a new report that highlights

The aggressive type of cancer accounts for 13% of all lung cancer cases worldwide MAIA Biotechnology has announced that positive results from its preclinical

The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359 Imperial College Healthcare NHS Trust (ICHT) and Imperial College London (ICL)

The projects will focus on healthcare in LMICs in the event of extreme weather The National Institute for Health and Care Research (NIHR) has

The chip removes cells, which could become tumours, before they are implanted in a patient Researchers from the Massachusetts Institute of Technology (MIT) and

The platform delivers digitalised patient data to improve clinical trials and development Phesi has announced that its artificial intelligence (AI)-driven Trial Accelerator platform has

M+F Health has announced the appointment of Sarah Jones as a Director M+F Health has announced the appointment of Sarah Jones as a Director. Sarah joins the

Decisive Consulting has appointed Chris Grimes-Crompton to its leadership team Decisive Consulting has appointed Chris Grimes-Crompton to lead its global commercial strategy efforts and become a member

The rare neurodevelopmental condition CDKL5 is characterised by early-onset epilepsy Researchers from the Francis Crick Institute have identified a new treatment target for cyclin-dependent

OART is increasingly emerging to assess and adapt treatment for cancer patients The Royal Marsden NHS Foundation Trust is set to implement online adaptive

The cell could be a target for new immunotherapies for the chronic disease Researchers from McMaster University and the pharmaceutical company ALK-Abello have discovered

The committee has advised that the vaccine should be given to those at the highest risk The Joint Committee on Vaccination and Immunisation (JCVI)

The new products are in the areas of gastrointestinal and respiratory medicines ALTURiX has announced that it has acquired exclusive rights to three new

The HTA reported that Brainomix 360 improved access to treatment for stroke patients The National Institute of Health and Care Excellence (NICE) has issued

Hypoxic-ischaemic encephalopathy affects around three million babies worldwide every year Researchers from Imperial College London have revealed that a blood test can pinpoint the

The biodegradable polymer scaffold encourages the body to grow new tissue Researchers at Harefield Hospital and Imperial College London’s (ICL) National Heart and Lung

The aggressive brain cancer is responsible for over 3,000 cases in the UK every year Researchers from King’s College London (KCL) have developed an

The neurodegenerative condition currently affects over 944,000 people in the UK A new programme led by Queen Mary University of London and funded by

Over 10,000 pharmacies in England will be offering the new advanced service The NHS has announced the launch of Pharmacy First, which allows patients

A career in modern clinical research must attract diversity Many face a roadblock when shifting careers, encountering a catch-22 of needing experience for a

A company’s ability to continuously attract talent is a crucial part of its success. Significant global challenges in recent years however, have forced organisations

Camena has appointed Dr Nicola Thompson as Chair of its Board Camena Bioscience – a synthetic biology company providing genes to the pharmaceutical and

Individuals with Jewish ancestry are six times more likely to carry a genetic fault The NHS has announced the launch of a new BRCA

Dopamine neuron senescence is a hallmark of Parkinson’s disease Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Columbia University Vagelos College of Physicians

Tumours with high mtDNA mutations more likely to respond to Opdivo Scientists from the Cancer Research UK Scotland Institute and Memorial Sloan Kettering Cancer

Prescriptions ordered via the app are expected to save around 1.85 million hours in 2024 NHS England has announced that its new digital prescription

Broken String has appointed Gavin Burns as VP of Quality and Operations Broken String Biosciences – a genomics company – has announced the appointment of Gavin Burns as

The institute is one of two UK laboratories wholly funded by the MRC The Medical Research Council (MRC) has opened a new Laboratory of

Around one million adults in the UK visit their GP every year due to chest pain Researchers from Keele University have identified the key

Type 2 diabetes is estimated to affect 462 million people worldwide An international academic consortium led by Johns Hopkins University, US, the Chinese University

A total of 103,277 general and acute beds are now available to NHS patients New figures have shown an increase of an additional 5,000

The EST identified 30% of patients with a blood supply/demand mismatch Researchers from King’s College London (KCL) have revealed that the revival of a

Around 50% of babies born with the condition are affected by heart defects Researchers from the Francis Crick Institute and University College London have

CAD is responsible for around 68,000 deaths per year in the UK PlaqueTec and the Babraham Institute’s Flow Cytometry facility have announced a collaboration

HPV is a common group of viruses which can sometimes lead to cancer The NHS is urging both parents and young people between the

In 2022, over 39,000 people in England died prematurely of cardiovascular conditions The British Heart Foundation (BHF) has revealed new data showing that early

The pharma industry is undergoing a profound transformation with the introduction of legislative reforms and the adoption of electronic patient information (ePI). Indeed, ePI

Patients living with sickle cell disease and thalassaemia will be eligible for the test The NHS has announced that it is the first healthcare

The new company will develop novel therapies to benefit the body’s immune system Oxitope Pharma and Arxx Therapeutics have announced their merger to form

The advancement could allow earlier detection of cancer in the blood and better treatment Researchers from the Massachusetts Institute of Technology (MIT) and the

Autosomal dominant polycystic kidney disease affects more than 12 million people globally Researchers at the Massachusetts Institute of Technology (MIT) and Yale University School

Approximately 48,000 deaths in the UK occur from sepsis every year The Great Western Hospitals NHS Foundation Trust has partnered with the training platform,

Approximately one in five children will be hospitalised to treat measles The NHS has announced the launch of its new catch up campaign to

Company will present vital findings at SRI annual meeting Serac Healthcare – a clinical radiopharmaceutical company – has announced that an abstract on vital

New stroke therapy delivers electrical pulses to the brain A new stroke therapy which delivers electrical pulses to the brain via a portable, pacemaker-type

Company is focused on endocannabinoid system treatments Synendos Therapeutics – a company focused on innovative endocannabinoid system (ECS) treatments – has announced that it

Green light concerns generalised myasthenia gravis therapy The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Zilbrysq as an add-on

Data supports Poolbeg’s strategic expansion of POLB 001 Poolbeg – a company focused on innovative medicines – has announced promising in vivo results for

License agreement concerns development of cell therapies for corneal blindness ERS Genomics Limited (ERS) – a company formed to provide wider access to foundational

Aston University to create the Aston Institute for Membrane Excellence Aston University is on course to create the Aston Institute for Membrane Excellence (AIME)

EUR 20m to identify new targets and develop first in class drugs DISCO Pharmaceuticals – a company specialising in unlocking the surfaceome of cancer

Companies collaborate to launch walk-in pain clinic Kanabo Group has linked up with City Dock Pharmacy in London, to introduce a walk-in pain clinic

CellVoyant’s platform combines AI with live cell imaging CellVoyant – an AI biotechnology spin-out from the University of Bristol – has announced a £7.6

The nine-week DTxl CBT helps to address psychological symptom burdens in PF patients Vicore Pharma has announced positive results for its digital cognitive behavioural

Both aim to advance the use of AI-powered cell analysis for cancer, stem cell and cell therapies Deepcell has entered into a research collaboration

Researchers compared 20 years of antibiotic use on E. coli in the UK and Norway Researchers from the Wellcome Sanger Institute, the University of

If successful, the new test could see routine screening introduced in the NHS Researchers at Cambridge University Hospitals NHS Foundation Trust and the University

New fleet of ultrasound machines at NHS Nightingale Hospital Exeter With a quarter of the population now on the NHS waiting list , reducing

The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser Engineers from the Massachusetts Institute of Technology (MIT) have designed

In 2022, around 8% of patients survived 30 days after a cardiac arrest New data published by the Out-of-Hospital Cardiac Arrest Outcomes (OHCAO) Registry,

The £30m ADVANCE study is the most extensive study into liver disease worldwide A new study involving Boehringer Ingelheim, Newcastle University and the University

The partnership will advance VTP-500 from early development to phase 2 clinical trials Barinthus Biotherapeutics has announced a new partnership with the Coalition for

The fertilised eggs could cultivate tumours for imaging within seven days Researchers from King’s College London (KCL) have identified that fertilised chicken eggs could

The number of people getting tested over the last decade has increased by 133% The NHS has announced a new analysis showing its highest

The companies will aim to select targets, discover and develop new therapeutics Owkin and Evotec have entered into an artificial intelligence (AI)-powered strategic partnership

Vd1-gd T cells were effective in predicting positive responses to ICI therapy Researchers from King’s College London (KCL), Guy’s and St Thomas’ Hospital Trust

Metastatic cancer is estimated to be responsible for 90% of cancer deaths Researchers from the University of Eastern Finland and Kuopio University Hospital have

High amounts of disrupted sleep were found to affect memory and thinking performance Researchers from the University of California have suggested an association between

NaviCam ProScan is the first AI-assisted reading tool for gastrointestinal bleeding AnX Robotica has announced that the US Food and Drug Administration (FDA) has

The new hub will be located in the King’s Cross Knowledge Quarter, London Novo Nordisk has announced its plans to open a new, artificial

The programme is the only remote, digital delivery nursing home training programme for dementia King’s College London and the University of Exeter have announced

The condition affects around 270,935 people in England and 16,090 people in Wales The National Institute for Health and Care Excellence (NICE) has published

Slow-growing cancer cells become more resistant to chemotherapy treatment Researchers from University College London (UCL) and Yale University have found that

The software has reduced the time to provide pathology data from days to hours The National Institutes of Health (NIH)-funded AIDS